ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Events

Anavex Life Sciences (AVXL)

NASDAQ

$3.88

$-0.07

(-1.77%)

Anavex Life Sciences (AVXL) Live Price Chart

Page last updated: 2026-02-12 00:23:00

Key Market Data

Market Cap	$346.67M
Open	$3.97
High	$31.50
Low	$1.25
Previous Close	$3.96
Price Change	$-0.07
Percentage Change	-1.77%
Volume	1M

Anavex Life Sciences (AVXL) Stock Price Today

Anavex Life Sciences (AVXL) is currently trading at $3.88 as of 2026-02-12 00:23:00, reflecting a -1.77% move ($-0.07) from the previous close.

In the short term, the stock has returned -1,637.93% over the past four weeks. Over the last 12 months, Anavex Life Sciences has recorded a -53.20% price change, indicating a weak performance relative to the broader market.

Anavex Life Sciences (AVXL) 7-Day Stock Price Changes

Over the past seven days, Anavex Life Sciences has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $4.14 to the latest recorded price of $3.88, reflecting an intraday change of -1.77%. Daily movements highlight shifts in trading volume (1,407,223), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, AVXL has delivered a -1,637.93% return over the past month and a -53.20% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Anavex Life Sciences (AVXL)

You can buy and trade AVXL on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for AVXL and Execute Your Trade

Open the trading page, enter AVXL in the search bar, select the amount of AVXL you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Anavex Life Sciences (AVXL)?

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Anavex Life Sciences Information

Industry	BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Employees	34
Sector	BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Company Website	https://www.anavex.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Anavex Life Sciences?

The latest trading price for Anavex Life Sciences (Common Stock) is $ 3.88, compared with a previous closing price of $ 3.96. That means the stock has moved -1.77% so far today. Intraday price updates and recent trading activity for AVXL can be tracked on the live chart and quote section on this page.

2.Is Anavex Life Sciences stock going up or down?

Looking at recent performances, AVXL has returned -1,637.93% over the past month, -59.54% over the last six months and -53.20% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Anavex Life Sciences stock, but keep in mind that past returns do not guarantee future results.

3.Where does AVXL currently sit relative to its 52-week high and low?

In the most recent 52-week period, Anavex Life Sciences has traded between a low of $ 2.86 and a high of $ 13.99. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether AVXL is currently nearer the top or the bottom of its one-year trading band.

4.How is Anavex Life Sciences classified by sector and industry?

Anavex Life Sciences is classified in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. In practice, this means Anavex Life Sciences is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing AVXL’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector could influence Anavex Life Sciences’s performance.

5.Where is Anavex Life Sciences listed and how large is it by market value?

Anavex Life Sciences is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 346.67M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Anavex Life Sciences's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does AVXL's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.45 summarises how much profit Anavex Life Sciences has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Anavex Life Sciences's financial performance over time?

To follow Anavex Life Sciences's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how AVXL is performing and how the market is responding.

8.When is Anavex Life Sciences expected to report earnings?

Anavex Life Sciences's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for AVXL, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Anavex Life Sciences's earnings reports?

Anavex Life Sciences's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether AVXL is meeting, beating or missing expectations.

10.How can I stay informed about Anavex Life Sciences's results and guidance?

You can stay up to date on Anavex Life Sciences by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for AVXL on this page helps you see how new information is being reflected in the stock.

11.Does Anavex Life Sciences pay a regular cash dividend to its shareholders?

Anavex Life Sciences Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor AVXL's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for AVXL?

Based on the latest earnings data, AVXL has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Anavex Life Sciences is an attractive income stock. The dividend payout ratio measures what percentage of earnings Anavex Life Sciences distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Anavex Life Sciences?

Anavex Life Sciences is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is AVXL valued in terms of P/E ratio and EPS?

Anavex Life Sciences currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.45. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Anavex Life Sciences's earnings. Comparing AVXL's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Anavex Life Sciences

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalisation

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

American Superconductor Corp.

AMSC

Charter Comm Inc Del CL A New

CHTR

Core Scientific, Inc.

CORZ

Crocs, Inc.

CROX

FACT II Acquisition Corp.

FACT

Top Gainers

Browse today's leading gainers in the US stock market

Greenlane Holdings, Inc.

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

AVXL-to-USD Calculator

Amount

AVXL

USD

1 AVXL = 3.88 USD